Tech Company Financing Transactions
Cellply Funding Round
On 10/2/2023, Cellply raised $3.8 million in funding from LIFTT, Recomec and Schia Venture.
Transaction Overview
Company Name
Announced On
10/2/2023
Transaction Type
Venture Equity
Amount
$3,790,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Via Fondazza 53
Bologna, 40125
IT
Bologna, 40125
IT
Phone
Website
Email Address
Overview
Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma companies and research institutes from discovery to R&D and quality control of advanced therapies. Our team features a unique combination of expertise in a diverse set of technology going from microfluidics to robotics, AI, biology and immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emiliano Spagnolo
Chief Technical Officer
Andrea Faenza
Founder
Massimo Bocchi
Browse more venture capital transactions:
Prev: 10/2/2023: Titan Flood venture capital transaction
Next: 10/3/2023: Stampli venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs